References
- Ewald N, Hardt PD, Kloer HU. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr. Opin. Lipidol. 20(6), 497–504 (2009).
- Murphy MJ, Sheng X, Macdonald TM, Wei L. Hypertriglyceridemia and acute pancreatitis. JAMA Intern. Med. 173(2), 162–164 (2013).
- Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf. 29(12), 1123–1132 (2006).
- Keech A, Simes RJ, Barter P et al.; FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with Type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366(9500), 1849–1861 (2005).
- Baigent C, Landray MJ, Reith C et al.; SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377(9784), 2181–2192 (2011).
- No authors listed. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N. Engl. J. Med. 296(21), 1185–1190 (1977).
- Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 8(5), 1147–1150 (1988).
- von Bergmann K, Leiss O. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia. Eur. J. Clin. Invest. 14(2), 150–154 (1984).
- Preiss D, Tikkanen MJ, Welsh P et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 308(8), 804–811 (2012).
- Baigent C, Blackwell L, Emberson J et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376(9753), 1670–1681 (2010).
Websites
- National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). www.nhlbi.nih.gov/guidelines/cholesterol/ (Accessed 28 November 2012)
- National Institute for Health and Clinical Excellence. The management of Type 2 diabetes. www.nice.org.uk/nicemedia/live/12165/44320/44320.pdf (Accessed 28 November 2012)
- British National Formulary. Statins: side-effects. www.medicinescomplete.com/mc/bnf/current/PHP1623-statins.htm (Accessed 28 November 2012)
- US FDA. Endocrinologic and Metabolic Drugs Advisory Committee Briefing Document: SHARP (Study of Heart and Renal Protection). FDA website. Click here for link. (Accessed 28 November 2012)